Biogen (NASDAQ:BIIB – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Biogen and Poseida Therapeutics’ net […]
Virtual Annual Meeting of Stockholders All stockholders of record at the close of business on April 8, 2024, are invited to participate in the virtual Annual Meeting webcast,.
WESTON (dpa-AFX) - Biogen Inc. (BIIB) said that the European Commission has granted marketing authorization under exceptional circumstances and maintained orphan designation for Qalsody (tofersen)
Donidalorsen delivered significant and sustained reductions in HAE attacks, with high levels of disease control and improvement in quality of life measures with monthly or every two-month dosing;.